Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.3205/000223 | Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015) – short version |
| https://doi.org/10.3324/haematol.2017.178442 | A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia |
| https://doi.org/10.1038/s41375-023-01884-2 | Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia |
| https://doi.org/10.1159/000510258 | Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper |
| https://doi.org/10.1038/s41375-020-0839-4 | Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia |
| https://doi.org/10.1016/j.ejca.2021.01.033 | 2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy |
| https://doi.org/10.1038/s41375-023-02068-8 | Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG) |
| https://doi.org/10.1016/j.ejca.2020.09.009 | Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO) |
| https://doi.org/10.1038/s41375-024-02140-x | Prognostic impact of CEBPA mutational subgroups in adult AML |
| https://doi.org/10.1002/ijc.35332 | Targeting the Menin–KMT2A interaction in leukemia: Lessons learned and future directions |
| https://doi.org/10.1016/s1470-2045(25)00410-3 | Health-care transitions for young people living beyond childhood and adolescent cancer: recommendations from the EU–CAYAS–NET consortium |
| https://doi.org/10.1002/ijc.70197 | DNA methyltransferase inhibitors in hematological malignancies and solid tumors |
| https://doi.org/10.3324/haematol.2012.064667 | RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes |
| https://doi.org/10.3324/haematol.2014.104133 | Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse |
| https://doi.org/10.1007/s00277-011-1280-6 | Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML) |
| https://doi.org/10.1371/journal.pone.0089560 | Activating FLT3 Mutants Show Distinct Gain-of-Function Phenotypes In Vitro and a Characteristic Signaling Pathway Profile Associated with Prognosis in Acute Myeloid Leukemia |
| https://doi.org/10.1093/annonc/mdt522 | The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO) |
| https://doi.org/10.1038/leu.2014.186 | Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse |
| https://doi.org/10.1182/blood-2013-01-476473 | Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia |
| https://doi.org/10.1182/blood-2010-12-327072 | The FLT3ITD mRNA level has a high prognostic impact in NPM1 mutated, but not in NPM1 unmutated, AML with a normal karyotype |
| https://doi.org/10.1186/s13045-014-0055-7 | Long-term follow-up of cytogenetically normal CEBPA-mutated AML |
| https://doi.org/10.1038/leu.2013.297 | Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG |
| https://doi.org/10.1038/s41375-018-0268-9 | Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study |
| https://doi.org/10.1111/ejh.13788 | Acquired aplastic anemia following SARS‐CoV ‐2 vaccination |
| https://doi.org/10.1007/s10120-023-01424-y | German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer |
| https://doi.org/10.1016/j.ejca.2022.11.030 | AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants |
| https://doi.org/10.1002/ijc.35389 | Therapeutic targeting of chromatin alterations in leukemia and solid tumors |
| https://doi.org/10.1016/j.ejca.2026.116244 | Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancer |
| https://doi.org/10.1038/s41375-025-02644-0 | Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology) |
| https://doi.org/10.1055/s-2002-25151 | Chances and Shortcomings of Adenovirus-Mediated ATP7B Gene Transfer in Wilson Disease: Proof of Principle Demonstrated in a Pilot Study with LEC rats |
| https://doi.org/10.1371/journal.pone.0109759 | The NPM1 Mutation Type Has No Impact on Survival in Cytogenetically Normal AML |
| https://doi.org/10.1159/000355006 | Clinical Indications for Thrombopoietin and Thrombopoietin-Receptor Agonists |
| https://doi.org/10.1371/journal.pone.0125783 | Identification of the Adapter Molecule MTSS1 as a Potential Oncogene-Specific Tumor Suppressor in Acute Myeloid Leukemia |
| https://doi.org/10.1038/s41598-018-29593-2 | Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia |
| https://doi.org/10.1007/s00482-014-1412-8 | Schmerztherapie in der Onkologie |
| https://doi.org/10.1038/leu.2016.54 | Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia |
| https://doi.org/10.3238/arztebl.m2021.0277 | Complementary medicine in the treatment of cancer patients |
| https://doi.org/10.1002/cam4.4981 | Evaluating requests for physician‐assisted suicide. A survey among German oncologists |
| https://doi.org/10.1016/j.esmoop.2021.100329 | Role and responsibility of oncologists in assisted suicide. Practice and views among members of the German Society of Haematology and Medical Oncology |
| https://doi.org/10.1159/000356910 | Immunthrombozytopenie - Onkopedia-Leitlinien Update: Empfehlungen einer gemeinsamen Arbeitsgruppe der DGHO, ÖGHO, SGH + SSH und GPOH |
| https://doi.org/10.1016/j.ejca.2025.115331 | Precision oncology – Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology |
| https://doi.org/10.5482/ha-1174 | Venöse Thrombembolien bei Tumorpatienten |
| https://doi.org/10.1007/s00134-020-06002-9 | Ten things the hematologist wants you to know about CAR-T cells |
| https://doi.org/10.1007/s00277-023-05087-8 | Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study |
| https://doi.org/10.3390/jmahp12030011 | The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access Academy |
| https://doi.org/10.1016/j.xinn.2024.100719 | Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemia |
| https://doi.org/10.3390/jmahp13010006 | Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy |
| https://doi.org/10.1002/hem3.70183 | Clonal hematopoiesis in AML long‐term survivors: Risk factors and clinical consequences |
| https://doi.org/10.1016/j.autrev.2026.104043 | Expert perspectives on Myalgic encephalomyelitis/chronic fatigue syndrome – Insights from the 3rd International Conference of the Charité Fatigue Center |
| https://doi.org/10.1007/s00063-015-0039-6 | Letalität hämatoonkologischer Patienten in Neutropenie auf der Intensivstation |
| https://doi.org/10.1007/s00063-019-0532-4 | Der hämatologisch-onkologische Intensivpatient |
| https://doi.org/10.18154/rwth-conv-246988 | Advisory opinion of the AWMF Ad hoc Commission In-vitro Diagnostic Medical Devices regarding in-vitro diagnostic medical devices manufactured and used only within health institutions established in the Union according to Regulation (EU) 2017/746 (IVDR) |
| https://doi.org/10.5482/ha-1147 | Venous thrombembolism in tumour patients |
| https://doi.org/10.1182/blood.v126.23.3815.3815 | DNMT3A Mutations Associate with Shorter Survival and Modulate the Prognostic Impact of Mutated NPM1: an Analysis Based on Comprehensive Mutational Screening of 660 AML Patients Treated on German AML Cooperative Group (AMLCG) Trials |
| https://doi.org/10.1055/s-2005-916358 | Psycho-sozialer Distress als Begleitsymptom der Krebserkrankung |
| https://doi.org/10.1055/s-0038-1629332 | Prävention von Infektionen und Thrombosen nach Splenektomie oder funktioneller Asplenie |
| https://doi.org/10.1007/s00740-018-0218-1 | Krebspatienten in der operativen Intensivmedizin |
| https://doi.org/10.1007/978-3-642-41741-2 | Das Blaue Buch |
| https://doi.org/10.1159/000348254 | Akademische multizentrische Studien im Fokus: Auswirkungen der Arzneimittelgesetzgebung auf Therapieoptimierungsstudien in der Hämatologie/Onkologie |
| https://doi.org/10.3238/arztebl.2015.0009b | Several Flaws |
| https://doi.org/10.31205/pa.010.01 | Grenznahe Kooperation zwischen Deutschland und Polen |
| https://doi.org/10.1007/s00432-022-04489-x | What do hematologists and oncologists consider necessary for their career? Results of an online survey in Germany, Austria and Switzerland |
| https://doi.org/10.1111/bjh.18982 | Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome |
| https://doi.org/10.1097/01.hs9.0000968736.01444.45 | P457: COMPLEX CARYOTYPE IS AN INDEPENDENT RISK FACTOR IN TP53-MUTATED AML |
| https://doi.org/10.1159/000546550 | Guidelines of Onkopedia: What Is New? |
| https://doi.org/10.3390/jmahp14010005 | Development of a Performance Measurement Framework for European Health Technology Assessment: Stakeholder-Centric Key Performance Indicators Identified in a Delphi Approach by the European Access Academy |
| https://doi.org/10.1007/s11654-026-00714-y | Infektionen unter Therapie mit bispezifischen Antikörpern bei malignen Lymphomen, dem multiplen Myelom und der akuten lymphatischen Leukämie |
| https://doi.org/10.1016/j.ctrv.2026.103142 | Management of infections in the outpatient care of patients with cancer |
| https://doi.org/10.1007/s00262-015-1755-8 | RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML |
| https://doi.org/10.1159/000495145 | Position of Scientific Oncological Societies Towards Biosimilar Antibodies |
| https://doi.org/10.1159/000218579 | Die moderne Krebsbehandlung: Wissenschaftlich begründete Verfahren und Methoden mit unbewiesener Wirksamkeit |
| https://doi.org/10.1007/s00120-015-4007-9 | Herausforderung demographischer Wandel |
| https://doi.org/10.1007/s00101-018-0406-9 | Krebspatienten in der operativen Intensivmedizin |
| https://doi.org/10.1159/000348257 | Klinische Studien in der Onkologie - 2013 und zukünftig |
| https://doi.org/10.1007/s007610050419 | Ausbildung in Onkologie |
| https://doi.org/10.1159/000352000 | Neue Medikamente in der Onkologie: Nutzen, Risiken und Herausforderungen |
| https://doi.org/10.1182/blood.v124.21.2267.2267 | Up-Front Randomization 10 Years Later: The AML Cooperative Group Strategy |
| https://doi.org/10.31205/pa.033.01 | Wiederbelebung einer »Totgeburt«? Das Europäische Netzwerk Erinnerung und Solidarität |
| https://doi.org/10.1007/s12312-023-01210-y | Gemeinsames Positionspapier der onkologisch tätigen Fachgesellschaften der AWMF Ad hoc Kommission Versorgungsstrukturen zu der „Dritten Stellungnahme und Empfehlung der Regierungskommission für eine moderne und bedarfsgerechte Krankenhausversorgung mit grundlegender Reform der Krankenhausvergütung“ |
| https://doi.org/10.1007/s00761-011-2189-3 | Systemische Therapie in einem kurativen multimodalen Konzept |
| https://doi.org/10.1159/000363456 | Benefits and Risks of Cancer Screening |
| https://doi.org/10.1055/s-0038-1629174 | Diagnostik von primären Immundefekten |
| https://doi.org/10.1055/s-0036-1597742 | Erinnerungsort Krebsbaracke. Klarstellungen um das erste interdisziplinäre Krebsforschungsinstitut in Deutschland (Berlin, Charité) |
| https://doi.org/10.1007/s00740-013-0075-x | Zervixkarzinom |
| https://doi.org/10.1055/a-1267-0763 | Invasive Pilzinfektionen bei Intensivpatienten – Was gibt es Neues? |
| https://doi.org/10.1007/s00432-021-03746-9 | Ernst von Leyden (1832–1910): a pioneer in making oncology a respected medical discipline |
| https://doi.org/10.31205/pa.061.01 | Kohabitation nowy |
| https://doi.org/10.1007/s00761-023-01387-w | Therapiemonitoring der neoadjuvanten Radio‑/Chemotherapie |
| https://doi.org/10.1055/a-2227-3775 | Kriterien für die Behandlung von thoraxonkologischen Erkrankungen als stationäre Leistung bei Erwachsenen * |
| Effect of cerebral blood flow changes on 18F-florbetaben SUVR | |
| https://doi.org/10.1159/000380798 | Reports of Oncological Societies |
| https://doi.org/10.1007/s00761-023-01441-7 | Ärztlich assistierte Selbsttötung |
| https://doi.org/10.1101/2020.01.07.20016881 | Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with Acute Myeloid Leukaemia |
| https://doi.org/10.1159/000381526 | Title Page / Contents / Imprint / Guidelines for Authors |
| https://doi.org/10.1159/000217396 | Stellungnahme der Arbeitsgemeinschaft Internistische Onkologie in der Deutschen Krebsgesellschaft e.V. und der Deutschen Gesellschaft für Hämatologie und Onkologie zu den Empfehlungen der Deutschen Krebsgesellschaft bezüglich der Ausstattung von klinischen Einrichtungen für Phase-I- und Phase-IIa-Medikamentenprüfungen in der Onkologie |
| https://doi.org/10.1159/000055102 | The Situation of Elderly Cancer Patients |
| https://doi.org/10.3413/nukmed-0318 | Guideline for radioimmunotherapy of CD20+ follicular B-cell non-Hodgkin's lymphoma |
| https://doi.org/10.1007/978-3-642-60881-0_16 | Interdisziplinäre Leitlinien: Cholelithiasis |
| https://doi.org/10.1515/labm.1995.19.1-12.328 | Erythrocytenzahlbestimmung: Vergleich von Impedanz- und Trübungsmessung bei ausgewählten Krankheitsbildern |
| https://doi.org/10.3238/arztebl.2015.0010b | Unsustainable Claims |